glp 1 drugs australia Researchers in are raising flags about GLP-1 weight-loss medications potentially raising the risk of a rare disease. Scurvy Scam weight-loss drops marketed to
Description
Modulation of glucose-induced insulin secretion from a rat clonal beta-cell line

Whats next in the pipeline

These drugs, which stimulate insulin release and reduce appetite, offer promising therapeutic options for managing blood sugar levels and supporting weight loss in individuals with these conditions
2017, Frias et al

The search strategy employed the following terms: (Incretin Mimetics OR GLP-1 receptor agonists) AND (pancreatic cancer OR pancreatic adenocarcinoma OR pancreatic effects)
